Euphrasia officinalis

Eyebright/Drug Interactions:

  • Cytochrome P450 (CYP 450) Metabolized AgentsCytochrome P450 (CYP 450) Metabolized Agents: Theoretically, eyebright may interact with medications that are metabolized by CYP 450. An animal study conducted on rat livers demonstrated inhibition of CYP 450 by the aglycone of aucubin (4). However, this effect has not been evaluated in humans.
  • Hypoglycemic Agents, InsulinHypoglycemic Agents, Insulin: Theoretically, eyebright may interact with medications that alter blood glucose levels. In a rat study, eyebright was found to exert no hypoglycemic effects in normal animals, although in rats with chemically induced diabetes, glucose levels were reduced (3).

    • Eyebright/Herb/Supplement Interactions:

  • Cytochrome P450 (CYP 450) Metabolized Herbs and SupplementsCytochrome P450 (CYP 450) Metabolized Herbs and Supplements: Theoretically, eyebright may interact with agents that are metabolized by CYP 450. An animal study conducted on rat livers demonstrated inhibition of CYP 450 by the aglycone of aucubin (4). However, this effect has not been evaluated in humans.
  • Hypoglycemic Herbs/SupplementsHypoglycemic Herbs/Supplements: Theoretically, eyebright may interact with medications that alter blood glucose levels. In a rat study, eyebright was found to exert no hypoglycemic effects in normal animals, although in rats with chemically-induced diabetes, glucose levels were reduced (3).

    • Eyebright/Food Interactions:

  • Insufficient available evidence.

    • Eyebright/Lab Interactions:

  • Insufficient available evidence.